AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Manufacturing, Marketing And Distribution Agreements Between Biotech And
Pharmaceutical Companies: March 25 -- May 21, 2003 #
Biotech Co. * Pharma Co.
(Country; Symbol) (Country)
Bioenvision Inc. Penn Pharmaceutical
(OTC BB: BIOV) Services Ltd. (UK)
BioTime Inc. CJ Corp.
(AMEX:BTX) (South Korea)
Celgene Corp. GlaxoSmithKline plc
(CELG) (UK)
Eyetech Pharmaecuticals Inc. * Pfizer Inc.
Labopharm Inc. Gruppo Angelini
(Canada; TSE:DDS) (Italy) and Esteve
SA (Spain)
TolerRx Inc. * Laureate Pharma LP
United Therapeutics Corp. Caremark Inc.
(UTHR)
Biotech Co. * Product
(Country; Symbol)
Bioenvision Inc. Clofarabine
(OTC BB: BIOV)
BioTime Inc. Hextend and PentaLyte
(AMEX:BTX) blood plasma volume
expanders
Celgene Corp. Alkeran
(CELG)
Eyetech Pharmaecuticals Inc. * Xalatan
Labopharm Inc. A once-daily version of the
(Canada; TSE:DDS) analgesic tramadol
TolerRx Inc. * Monoclonal antibodies
United Therapeutics Corp. Remodulin
(UTHR)
Biotech Co. * Terms/Details (Date)
(Country; Symbol)
Bioenvision Inc. Penn Pharmaceutical will
(OTC BB: BIOV) label, package, store and
distribute clofarabine in
Europe (5/15)
BioTime Inc. Exclusive licensing agreement
(AMEX:BTX) for CJ to manufacture and sell
the expanders in South Korea
for human therapeutic uses;
...